NCT03374371View on ClinicalTrials.gov

Invasive Markers of Staphylococcus Epidermidis

CompletedOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

December 18, 2020

Study Completion Date

December 18, 2020

Conditions
Staphylococcus Epidermidis Positive Blood Culture
Interventions
DIAGNOSTIC_TEST

high-throughput sequencing

technique of high-throughput sequencing of the markers present in the genome of the S. epidermidis strains responsible for infection in order to help to discriminate the true infections of the contaminations

Trial Locations (1)

75015

Hôpital Necker Enfants Malades, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03374371 - Invasive Markers of Staphylococcus Epidermidis | Biotech Hunter | Biotech Hunter